An anonymous director reports

CRESCO LABS TO REPORT FOURTH QUARTER 2024 FINANCIAL RESULTS ON MARCH 12, 2025

Cresco Labs Inc. will release financial results for the fourth quarter and year ended Dec. 31, 2024, on Wednesday, March 12, 2025, before the market opens.

The company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event:  Cresco Labs fourth quarter 2024 earnings conference call

Date:  Wednesday, March 12, 2025

Time:  8:30 a.m. ET

Dial-in numbers:  1-833-470-1428 (United States toll-free), 1-404-975-4839 (United States local)

Access code:  680910

Archived access to the webcast will be available for one year on Cresco Labs' investor relations website.

About Cresco Labs Inc.

Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG (consumer packaged goods) approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the company is leveraging its scale and agility to grow its portfolio of brands, including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's and Remedi, on a national level. The company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering continuing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, work force development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible.